Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Resource Type
Article
Authors
Dimopoulos, Meletios A ; Trotman, Judith ; Tedeschi, Alessandra ; Matous, Jeffrey V ; Macdonald, David ; Tam, Constantine ; Tournilhac, Olivier ; Ma, Shuo ; Oriol, Albert ; Heffner, Leonard T ; Shustik, Chaim ; García-Sanz, Ramón ; Cornell, Robert F ; de Larrea, Carlos Fernández ; Castillo, Jorge J ; Granell, Miquel ; Kyrtsonis, Marie-Christine ; Leblond, Veronique ; Symeonidis, Argiris ; Kastritis, Efstathios ; Singh, Priyanka ; Li, Jianling ; Graef, Thorsten ; Bilotti, Elizabeth ; Treon, Steven ; Buske, Christian
Source
In The Lancet Oncology February 2017 18(2):241-250
Subject
Primary Research Articles
Language
ISSN
1470-2045